TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.3 0.0 (1.35%) --- 0.01 (2.67%) 0.01 (2.19%) --- --- 0.0 (1.35%) 0.0 (1.35%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.1596
Diluted P/E:
-0.1596
RSI(14) 1m:
46.78
VWAP:
0.31
RVol:

Events

Period Kind Movement Occurred At

Related News